In its latest research, Choice Equity Broking maintains BUY recommendation on technology major Infosys, revising the target price to Rs 1,810—implying a potential upside of 25.7% from current level
Motilal Oswal Financial Services has reiterated its BUY call on Laurus Labs, highlighting a robust earnings trajectory and strategic capital deployment in CDMO and generics segments.